JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.12% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 8.72% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GDP
2726
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $4.04M | ﹤0.01% |
402,387
-89,682
| -18% | -$872K |
|
2727
CALL
Suncor Energy
SU
$76.5B
| $4.04M | ﹤0.01% |
123,100
| – | – |
|
|
2728
PUT
Suncor Energy
SU
$76.5B
| $4.04M | ﹤0.01% |
123,100
| – | – |
|
|
ARD
2729
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $4.04M | ﹤0.01% |
206,077
-21,942
| -10% | -$404K |
|
2730
CALL
Williams Companies
WMB
$89.3B
| $4.03M | ﹤0.01% |
170,000
-290,200
| -63% | -$6.65M |
|
|
2731
PUT
Williams Companies
WMB
$89.3B
| $4.03M | ﹤0.01% |
170,000
-97,500
| -36% | -$2.23M |
|
|
PTLA
2732
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.03M | ﹤0.01% |
168,757
+120,256
| +248% | +$3.32M |
|
|
CMD
2733
DELISTED
Cantel Medical Corporation
CMD
| $4.03M | ﹤0.01% |
56,847
-1,670
| -3% | -$121K |
|
2734
Assembly Biosciences
ASMB
$536M
| $4.03M | ﹤0.01% |
16,410
-6,666
| -29% | -$1.23M |
|
2735
Vanguard Russell 1000 Growth ETF
VONG
$46.2B
| $4.02M | ﹤0.01% |
88,952
+12,652
| +17% | +$543K |
|
|
AAMI
2736
Acadian Asset Management
AAMI
$3.31B
| $4.02M | ﹤0.01% |
393,255
-1,546,544
| -80% | -$15.1M |
|
2737
PUT
Vipshop
VIPS
$6.94B
| $4.01M | ﹤0.01% |
282,900
| – | – |
|
2738
Codexis
CDXS
$175M
| $4M | ﹤0.01% |
250,402
+221,627
| +770% | +$3.28M |
|
|
CS
2739
DELISTED
Credit Suisse Group
CS
| $4M | ﹤0.01% |
297,560
+284,602
| +2,196% | +$3.64M |
|
2740
PUT
Peloton Interactive
PTON
$2.44B
| $4M | ﹤0.01% |
+140,900
| New | +$3.8M |
|
2741
Pediatrix Medical
MD
$2.15B
| $4M | ﹤0.01% |
143,921
-88,217
| -38% | -$2.21M |
|
2742
Franklin Electric
FELE
$4.75B
| $3.99M | ﹤0.01% |
69,600
+50,543
| +265% | +$2.67M |
|
|
TDAY
2743
USA Today Co
TDAY
$1.01B
| $3.99M | ﹤0.01% |
625,109
+32,872
| +6% | +$241K |
|
2744
NVE Corp
NVEC
$563M
| $3.99M | ﹤0.01% |
55,877
+47,460
| +564% | +$3.09M |
|
2745
CALL
Marvell Technology
MRVL
$199B
| $3.98M | ﹤0.01% |
150,000
| – | – |
|
|
2746
PUT
Marvell Technology
MRVL
$199B
| $3.98M | ﹤0.01% |
150,000
| – | – |
|
2747
PUT
PNC Financial Services
PNC
$102B
| $3.98M | ﹤0.01% |
24,900
| – | – |
|
|
AIMT
2748
DELISTED
Aimmune Therapeutics
AIMT
| $3.97M | ﹤0.01% |
118,700
-10,015
| -8% | -$280K |
|
2749
PUT
ADT
ADT
$5.46B
| $3.96M | ﹤0.01% |
500,000
-55,200
| -10% | -$436K |
|
2750
iShares MSCI Germany ETF
EWG
$1.67B
| $3.96M | ﹤0.01% |
134,552
+5,976
| +5% | +$170K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.